MICHELI, VALERIA
 Distribuzione geografica
Continente #
EU - Europa 1.666
NA - Nord America 1.556
AS - Asia 1.320
SA - Sud America 151
AF - Africa 71
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.775
Nazione #
US - Stati Uniti d'America 1.511
CN - Cina 520
DE - Germania 446
IT - Italia 399
SG - Singapore 377
GB - Regno Unito 299
HK - Hong Kong 141
RU - Federazione Russa 117
BR - Brasile 112
SE - Svezia 95
IN - India 85
ID - Indonesia 75
FR - Francia 67
NL - Olanda 63
IE - Irlanda 46
CA - Canada 39
CI - Costa d'Avorio 38
FI - Finlandia 26
KR - Corea 22
DK - Danimarca 21
VN - Vietnam 20
TR - Turchia 17
CH - Svizzera 14
JP - Giappone 14
UA - Ucraina 14
AR - Argentina 13
CO - Colombia 11
AU - Australia 10
BE - Belgio 10
AT - Austria 8
ES - Italia 8
BD - Bangladesh 7
RO - Romania 6
SA - Arabia Saudita 6
ET - Etiopia 5
IR - Iran 5
MA - Marocco 5
PL - Polonia 5
UG - Uganda 5
ZA - Sudafrica 5
BG - Bulgaria 4
EC - Ecuador 4
MX - Messico 4
TW - Taiwan 4
KE - Kenya 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
SC - Seychelles 3
TH - Thailandia 3
TJ - Tagikistan 3
AM - Armenia 2
BY - Bielorussia 2
CL - Cile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GR - Grecia 2
IQ - Iraq 2
KZ - Kazakistan 2
LT - Lituania 2
OM - Oman 2
PH - Filippine 2
PK - Pakistan 2
PY - Paraguay 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
IL - Israele 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.776
Città #
Frankfurt am Main 359
Southend 263
Ashburn 233
Singapore 206
Milan 169
Chandler 148
Hong Kong 133
Dallas 108
Fairfield 105
Beijing 85
Seattle 69
Wilmington 56
Hefei 51
Dublin 45
Santa Clara 43
Jakarta 42
Princeton 42
Los Angeles 39
Woodbridge 39
Abidjan 38
Council Bluffs 38
Cambridge 37
Ann Arbor 36
Bengaluru 33
Guangzhou 30
Houston 29
Rome 29
Boardman 26
Phoenix 24
Munich 23
The Dalles 23
Toronto 23
Buffalo 21
Redwood City 21
Shanghai 21
Moscow 19
New York 18
Dearborn 17
Nanjing 16
Cangzhou 15
Columbus 15
São Paulo 15
Nuremberg 14
Margão 13
Turin 13
Tokyo 12
Des Moines 11
Segrate 11
Dong Ket 10
Istanbul 10
San Valentino Torio 10
Seoul 10
Helsinki 9
Medellín 9
San Diego 9
Fuzhou 8
London 8
Nanchang 8
Vienna 8
Brussels 7
Changsha 7
Jinan 7
Kent 7
Mumbai 7
Shenzhen 7
Ho Chi Minh City 6
Hyderabad 6
Montreal 6
Riyadh 6
Shenyang 6
St Petersburg 6
Turku 6
Wuhan 6
Zurich 6
Bexley 5
Boston 5
Cassano Magnago 5
Central District 5
Chicago 5
Düsseldorf 5
Falls Church 5
Fremont 5
Jacksonville 5
Kampala 5
Lappeenranta 5
Naples 5
Newark 5
Paris 5
Yongin-si 5
Zhengzhou 5
Addis Ababa 4
Amsterdam 4
Atlanta 4
Bandung 4
Berlin 4
Brooklyn 4
Colorado Springs 4
Melbourne 4
Nashik 4
Ottawa 4
Totale 3.191
Nome #
Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan 404
Improvement of ALT decay kinetics by all-oral HCV treatment : role of NS5A inhibitors and differences with IFN-based regimens 285
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 248
Favorable therapeutic response with an antiretroviral salvage regimen in an HIV-1-positive subject infected with a CRF11-cpx virus 208
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 201
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy : 48-Week results of a randomized trial 200
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response 197
Time and mode of epidemic hcv-2 subtypes spreading in Europe: Phylodynamics in Italy and Albania 196
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 192
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy 177
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 170
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022 165
Geographical reconstruction of the SARS‐CoV‐2 outbreak in Lombardy (Italy) during the early phase 156
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 150
Viral bloodstream detection in mpox patients: An observational multicentric study 145
Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy 142
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 140
Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI 135
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic 132
Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation 130
A perspective Italian study on HIV-1 resistance in naive patients for antiretroviral therapy 128
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 128
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy 125
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens 118
A case of extremely prolonged viral shedding: Could cell cultures be a diagnostic tool to drive COVID-19 patient discharge? 108
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy : Modeling from antiretroviral resistance cohort analysis (ARCA) national database 103
Two individuals with potential monkeypox virus reinfection 100
Persistent detection and sequencing of SARS-CoV-2 in the bloodstream of an immunocompromised patient 96
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 90
Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies 83
Immunological failure in an HIV élite controller: Possible role of indirect markers of inflammation and benefit of antiretroviral therapy 76
null 3
Totale 4.931
Categoria #
all - tutte 17.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.091


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021235 0 0 0 0 40 34 20 47 31 21 23 19
2021/2022439 29 24 35 10 43 25 34 21 52 58 14 94
2022/2023532 62 63 46 46 32 82 11 37 63 16 45 29
2023/2024716 23 41 34 40 150 54 70 65 28 48 76 87
2024/20251.185 77 115 54 124 83 65 62 93 65 134 112 201
2025/2026995 255 187 263 237 53 0 0 0 0 0 0 0
Totale 4.931